Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144494 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144682 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2021-08-27 | 2022-01-28 | 144691 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144694 |
| TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-08-27 | 2021-11-18 | 144707 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2021-08-27 | 2023-12-05 | 144715 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-08-27 | 2021-09-30 | 144718 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2021-08-27 | 2021-09-16 | 144721 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-08-27 | 2021-09-23 | 144726 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-08-27 | 2021-10-07 | 144733 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-27 | 2023-07-05 | 144747 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-27 | 2021-11-11 | 144755 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-08-27 | 2021-10-14 | 144769 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-02 | 2021-12-02 | 145106 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2021-09-09 | 145109 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |